Development of a standard treatment protocol for severe acute respiratory syndrome
- PMID: 12747883
- PMCID: PMC7112408
- DOI: 10.1016/s0140-6736(03)13265-5
Development of a standard treatment protocol for severe acute respiratory syndrome
Abstract
A series of 31 patients with probable SARS, diagnosed from WHO criteria, were treated according to a treatment protocol consisting of antibacterials and a combination of ribavirin and methylprednisolone. Through experience with the first 11 patients, we were able to finalise standard dose regimens, including pulsed methylprednisolone. One patient recovered on antibacterial treatment alone, 17 showed rapid and sustained responses, and 13 achieved improvement with step-up or pulsed methylprednisolone. Four patients required short periods of non-invasive ventilation. No patient required intubation or mechanical ventilation. There was no mortality or treatment morbidity in this series.
Figures
Comment in
-
Treatment of severe acute respiratory syndrome in health-care workers.Lancet. 2003 Dec 13;362(9400):2025-6. doi: 10.1016/S0140-6736(03)15036-2. Lancet. 2003. PMID: 14683674 Free PMC article. No abstract available.
References
-
- Lee N, Hui D, Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. http://content.nejm.org/cgi/reprint/NEJMoa030685v1.pdf (accessed April 22, 2003) - PubMed
-
- WHO Case definitions for surveillance of severe acute respiratory syndrome (SARS) http://www.who.int/csr/sars/casedefinition/en (accessed April 22, 2003)
-
- Cheung CY, Poon LL, Lau AS. Induction of postinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet. 2002;360:1831–1837. - PubMed
-
- Tsang KW, Ho PL, Ooi GC. A cluster of cases of severe acute respiratory syndrome in Hong Kong. http://content.nejm.org/cgi/reprint/NEJMoa030666v1.pdf (accessed April 22, 2003) - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
